Intranasal oxytocin has shown promise in improving neuropsychiatric symptoms in frontotemporal dementia, particularly in reducing apathy and enhancing expressions of empathy, thereby improving patient–caregiver interactions.50 The gene discussed is OXT; the disease is frontotemporal dementia.